GobizKOREA Launches the ‘2024 GobizWEEK Promotion’ for International Buyers
Discounts of up to 50%...
Omar Harfouch Gears Up to Launch “Concerto for Peace” Initiative for Global Unity
Paris, France – September 12, 2024...
“Ashes of the Kingdom” Breaks Barriers to Captivate the World: Chinese Female-Oriented Games Showcase Global Impact
SINGAPORE, Sept 11, 2024 –...
Scorpion Protective Coatings Named One of America’s Top 100 Small Businesses
U.S. Chamber of Commerce CO-100...
Singapore New City Association Supports Low-Income Families
On April 12, 2023, the...
The First of Omar Harfouch’s Global Concerto for Peace Performances
Paris, France – September 11, 2024...
Fast Debt Recovery Specialist Among First Licensed Under Singapore’s New Debt Collection Rules
With their 100% compliance rate,...
BrilliantCrypto Launches Mobile App for Scholars
Tokyo, Japan – September 04, 2024...
Skyecap Celebrates Remarkable 489% Increase in Clientele
Sydney, Australia – September 03, 2024...
DR.NOAH BIOTECH’s AI-driven ALS Medicine Receives U.S. FDA Approval for Phase 1 Clinical Trial IND
Seoul, Korea – September 02, 2024...
LINK Business Brokers Brisbane Launches Educational Program for Business Sellers
Brisbane, Australia – August 31, 2024...
Dream Draw LLC FZ Expands to European Markets with Unique Shopping Model
Dubai, UAE – August 31, 2024...
GVRenting Unveils Sustainable Solutions in Urban Architecture
Green Above: How GVRenting’s Urban...
B2BROKER and Spotware Partnership – B2COPY Now Integrated with cTrader
New York, NY – August 29,...
maXwin, the Leading Online Gaming Platform Breaks into the Asian Market
Asia’s Only Online Gaming Platform...
守护健康与爱，醴厚生医：将“利他”精神融入每一款产品
Singapore - 2024年8月27日 - (SeaPRwire) - 醴厚生医自成立以来，始终秉持着「利他」精神，致力于通过高质量的健康产品，唤醒人们对自身健康的关注，并将这份关爱延伸到身边每一个人。发言人陈欣佑在接受《The...
MVL Launches TADA mini Beta: Ride-Hailing Available via Telegram
Seoul, Korea – August 23, 2024...
Next-Level AML: XBO.com Integrates Elliptic’s Compliance Solution
Compliance being a pressing issue,...
China Medical System (00867) Released its 2024 Interim Results:Steady Increase in Revenue and Profit Compared with 2H 2023
CMS enters the “New Product...
亚洲公司突破Ac-225制备关键技术
磐美迪国际团队共同努力，完成Ac-225量产核心技术工艺验证 伦敦，2024年8月15日 - (SeaPRwire) - 2024年8月，磐美迪控股(深圳)有限公司在国际团队共同的努力和权威专家的见证下，于英国伦敦发布突破新型医用同位素Ac-225关键性生产技术的消息，该技术同时得到了英国知名研究型大学的严格验证，为磐美迪在Ac-225的规模商业化量产方面又迈进了具有里程碑意义的一步。...